This week in transparency news: February 9 – February 15, 2019

by Staff writer,
Posted on 2/15/2019

Transparency in clinical trials is continually changing, and to stay on top of the news, TrialAssure brings a weekly round-up of some of the key stories surrounding disclosures in clinical trials. This week’s stories are as follows:

Switzerland clinical trial reporting to be required in 2021 –Swiss Radio & Television

Research shows that almost 20 percent of clinical studies in Switzerland are unpublished, making the results inaccessible to key stakeholders. After physicians, researchers, and patients raised concern, the country plans to make clinical trial reporting a legal requirement in 2021.

Read the article via SRF

Boehringer Ingelheim, IBM to integrate blockchain technology into clinical trials Xtalks

Canadian companies Boehringer Ingelheim and IBM Canada announced their plans to integrate blockchain technology in clinical trials. This is the first time blockchain technology will be explored in Canadian clinical trials.

Read the full article by Candice Tang, MSc

STUDY: Publicizing trial results before peer reviewBMJ

Recently published in the BMJ, two physicians studied the consequences of publishing clinical trial data via press release, before it is peer-reviewed. The physicians noted that this is a recent trend and point out some transparency problems and ethical ambiguities.

Read the full study here

Vivli holds community discussion about informed consent and data-sharing Vivli

Vivli held a community discussion regarding informed consent and data sharing in the pharmaceutical industry. Vivli executives discussed ICF template language for data sharing, GDPR regulations, and limitations of consent.

Read more about the event here

Share: